228 related articles for article (PubMed ID: 33554955)
1. Alpha-1 antitrypsin deficiency impairs lung antibacterial immunity in mice.
Ostermann L; Maus R; Stolper J; Schütte L; Katsarou K; Tumpara S; Pich A; Mueller C; Janciauskiene S; Welte T; Maus UA
JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33554955
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin G and neutrophil elastase play critical and nonredundant roles in lung-protective immunity against Streptococcus pneumoniae in mice.
Hahn I; Klaus A; Janze AK; Steinwede K; Ding N; Bohling J; Brumshagen C; Serrano H; Gauthier F; Paton JC; Welte T; Maus UA
Infect Immun; 2011 Dec; 79(12):4893-901. PubMed ID: 21911460
[TBL] [Abstract][Full Text] [Related]
3. Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome?
Abboud RT; Ford GT; Chapman KR
Treat Respir Med; 2005; 4(1):1-8. PubMed ID: 15725045
[TBL] [Abstract][Full Text] [Related]
4. Type 1 diabetes contributes to combined pulmonary fibrosis and emphysema in male alpha 1 antitrypsin deficient mice.
Park SS; Mai M; Ploszaj M; Cai H; McGarvey L; Mueller C; Garcia-Arcos I; Geraghty P
PLoS One; 2023; 18(10):e0291948. PubMed ID: 37819895
[TBL] [Abstract][Full Text] [Related]
5. The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency.
McCarthy C; Reeves EP; McElvaney NG
Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S297-304. PubMed ID: 27564664
[TBL] [Abstract][Full Text] [Related]
6. Alpha-1 Antitrypsin-Deficient Macrophages Have Increased Matriptase-Mediated Proteolytic Activity.
Krotova K; Marek GW; Wang RL; Aslanidi G; Hoffman BE; Khodayari N; Rouhani FN; Brantly ML
Am J Respir Cell Mol Biol; 2017 Aug; 57(2):238-247. PubMed ID: 28362108
[TBL] [Abstract][Full Text] [Related]
7. Protease-Specific Biomarkers to Analyse Protease Inhibitors for Emphysema Associated with Alpha 1-Antitrypsin Deficiency. An Overview of Current Approaches.
Viglio S; Bak EG; Schouten IGM; Iadarola P; Stolk J
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494436
[TBL] [Abstract][Full Text] [Related]
8. Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions.
Hazari YM; Bashir A; Habib M; Bashir S; Habib H; Qasim MA; Shah NN; Haq E; Teckman J; Fazili KM
Mutat Res Rev Mutat Res; 2017 Jul; 773():14-25. PubMed ID: 28927525
[TBL] [Abstract][Full Text] [Related]
9. Sex-specific differences in emphysema using a murine antisense oligonucleotide model of α-1 antitrypsin deficiency.
Joshi R; Ojha M; Lewis J; Fan Q; Monia B; Guo S; Varisco BM
Am J Physiol Lung Cell Mol Physiol; 2019 Jun; 316(6):L1165-L1173. PubMed ID: 31017014
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase.
Jonigk D; Al-Omari M; Maegel L; Müller M; Izykowski N; Hong J; Hong K; Kim SH; Dorsch M; Mahadeva R; Laenger F; Kreipe H; Braun A; Shahaf G; Lewis EC; Welte T; Dinarello CA; Janciauskiene S
Proc Natl Acad Sci U S A; 2013 Sep; 110(37):15007-12. PubMed ID: 23975926
[TBL] [Abstract][Full Text] [Related]
11. Safety of Intravenous Administration of an AAV8 Vector Coding for an Oxidation-Resistant Human α1-Antitrypsin for the Treatment of α1-Antitrypsin Deficiency.
Rosenberg JB; De BP; Greco A; Gorman N; Kooner V; Chen A; Yost-Bido M; Munoz-Zuluaga C; Kaminsky SM; Rostami M; Monette S; Crystal RG; Sondhi D
Hum Gene Ther; 2023 Feb; 34(3-4):139-149. PubMed ID: 36606685
[TBL] [Abstract][Full Text] [Related]
12. Alpha-1 Antitrypsin Deficiency: Beyond the Protease/Antiprotease Paradigm.
Cosio MG; Bazzan E; Rigobello C; Tinè M; Turato G; Baraldo S; Saetta M
Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S305-10. PubMed ID: 27564665
[TBL] [Abstract][Full Text] [Related]
13. Historical role of alpha-1-antitrypsin deficiency in respiratory and hepatic complications.
Zuo L; Pannell BK; Zhou T; Chuang CC
Gene; 2016 Sep; 589(2):118-22. PubMed ID: 26768576
[TBL] [Abstract][Full Text] [Related]
14. Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.
Chiuchiolo MJ; Crystal RG
Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4(Suppl 4):S352-69. PubMed ID: 27564673
[TBL] [Abstract][Full Text] [Related]
15. Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications.
Chapman KR; Chorostowska-Wynimko J; Koczulla AR; Ferrarotti I; McElvaney NG
Int J Chron Obstruct Pulmon Dis; 2018; 13():419-432. PubMed ID: 29430176
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin.
Sosulski ML; Stiles KM; Frenk EZ; Hart FM; Matsumura Y; De BP; Kaminsky SM; Crystal RG
JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32759494
[TBL] [Abstract][Full Text] [Related]
17. alpha1-Antitrypsin deficiency: best clinical practice.
Kalsheker NA
J Clin Pathol; 2009 Oct; 62(10):865-9. PubMed ID: 19783716
[TBL] [Abstract][Full Text] [Related]
18. A review of alpha-1 antitrypsin deficiency.
Ranes J; Stoller JK
Semin Respir Crit Care Med; 2005 Apr; 26(2):154-66. PubMed ID: 16088434
[TBL] [Abstract][Full Text] [Related]
19. Alpha-1 Antitrypsin Deficiency Today: New Insights in the Immunological Pathways.
Baraldo S; Balestro E; Bazzan E; Tiné ME; Biondini D; Turato G; Cosio MG; Saetta M
Respiration; 2016; 91(5):380-5. PubMed ID: 27164860
[TBL] [Abstract][Full Text] [Related]
20. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ).
Hill AT; Campbell EJ; Bayley DL; Hill SL; Stockley RA
Am J Respir Crit Care Med; 1999 Dec; 160(6):1968-75. PubMed ID: 10588615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
